Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kristoffer Peterson

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Organic & Biomolecular Chemistry|January 12, 2019
Substituted polyfluoroaryl interactions with an arginine side chain in galectin-3 are governed by steric-, desolvation and electronic conjugation effectsRohit Kumar, Kristoffer Peterson, Majda Misini Ignjatović, et al.
Immunology|January 24, 2018
Galectin-3 is an amplifier of the interleukin-1β-mediated inflammatory response in corneal keratinocytesYuichi Uchino, Ashley M Woodward, Jérôme Mauris, et al.
Molecules (Basel, Switzerland)|December 18, 2019
3-Substituted 1-Naphthamidomethyl-C-galactosyls Interact with Two Unique Sub-sites for High-Affinity and High-Selectivity Inhibition of Galectin-3Alexander Dahlqvist, Santanu Mandal, Kristoffer Peterson, et al.
Chemmedchem|June 28, 2019
Structure and Energetics of Ligand-Fluorine Interactions with Galectin-3 Backbone and Side-Chain Amides: Insight into Solvation Effects and Multipolar InteractionsRohit Kumar, Majda Misini Ignjatović, Kristoffer Peterson, et al.
Chemmedchem|December 2, 2017
Monosaccharide Derivatives with Low-Nanomolar Lectin Affinity and High Selectivity Based on Combined Fluorine-Amide, Phenyl-Arginine, Sulfur-π, and Halogen Bond InteractionsFredrik R Zetterberg, Kristoffer Peterson, Richard E Johnsson, et al.
Journal of Medicinal Chemistry|December 7, 2023
Discovery of Selective and Orally Available Galectin-1 InhibitorsFredrik R Zetterberg, Carl Diehl, Maria Håkansson, et al.
Pharmacology|February 3, 2025
Pharmacological Characterization of GB1908, a Selective Galectin-1 Carbohydrate Binding Domain Inhibitor for the Treatment of CancerKimberly D Herman, Ian Holyer, Duncan C Humphries, et al.
ACS Chemical Biology|May 23, 2022
Galectin-9 Signaling Drives Breast Cancer Invasion through Extracellular MatrixDharma Pally, Mallar Banerjee, Shahid Hussain, et al.
RSC Advances|May 11, 2022
Aromatic heterocycle galectin-1 interactions for selective single-digit nM affinity ligandsKristoffer Peterson, Patrick M Collins, Xiaoli Huang, et al.
International Journal of Molecular Sciences|November 27, 2024
Galectin-1 Induces the Production of Immune-Suppressive Cytokines in Human and Mouse T CellsKimberly D Herman, Ian Holyer, Duncan C Humphries, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Organic & Biomolecular Chemistry|January 12, 2019
Substituted polyfluoroaryl interactions with an arginine side chain in galectin-3 are governed by steric-, desolvation and electronic conjugation effectsRohit Kumar, Kristoffer Peterson, Majda Misini Ignjatović, et al.
Immunology|January 24, 2018
Galectin-3 is an amplifier of the interleukin-1β-mediated inflammatory response in corneal keratinocytesYuichi Uchino, Ashley M Woodward, Jérôme Mauris, et al.
Molecules (Basel, Switzerland)|December 18, 2019
3-Substituted 1-Naphthamidomethyl-C-galactosyls Interact with Two Unique Sub-sites for High-Affinity and High-Selectivity Inhibition of Galectin-3Alexander Dahlqvist, Santanu Mandal, Kristoffer Peterson, et al.
Chemmedchem|June 28, 2019
Structure and Energetics of Ligand-Fluorine Interactions with Galectin-3 Backbone and Side-Chain Amides: Insight into Solvation Effects and Multipolar InteractionsRohit Kumar, Majda Misini Ignjatović, Kristoffer Peterson, et al.
Chemmedchem|December 2, 2017
Monosaccharide Derivatives with Low-Nanomolar Lectin Affinity and High Selectivity Based on Combined Fluorine-Amide, Phenyl-Arginine, Sulfur-π, and Halogen Bond InteractionsFredrik R Zetterberg, Kristoffer Peterson, Richard E Johnsson, et al.
Journal of Medicinal Chemistry|December 7, 2023
Discovery of Selective and Orally Available Galectin-1 InhibitorsFredrik R Zetterberg, Carl Diehl, Maria Håkansson, et al.
Pharmacology|February 3, 2025
Pharmacological Characterization of GB1908, a Selective Galectin-1 Carbohydrate Binding Domain Inhibitor for the Treatment of CancerKimberly D Herman, Ian Holyer, Duncan C Humphries, et al.
ACS Chemical Biology|May 23, 2022
Galectin-9 Signaling Drives Breast Cancer Invasion through Extracellular MatrixDharma Pally, Mallar Banerjee, Shahid Hussain, et al.
RSC Advances|May 11, 2022
Aromatic heterocycle galectin-1 interactions for selective single-digit nM affinity ligandsKristoffer Peterson, Patrick M Collins, Xiaoli Huang, et al.
International Journal of Molecular Sciences|November 27, 2024
Galectin-1 Induces the Production of Immune-Suppressive Cytokines in Human and Mouse T CellsKimberly D Herman, Ian Holyer, Duncan C Humphries, et al.
Pageof 2